Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jason Amello Insider Profile
11 Followers
Jason Amello, SVP, CFO & Treas at Akebia Therapeutics, holds 144.64K shares in Akebia Therapeutics (Ticker: AKBA), holds ― shares in Acer Therapeutics (Ticker: ACER), holds 202.01K shares in Candel Therapeutics (Ticker: CADL).
Jason Amello Akebia Therapeutics (AKBA)SVP, CFO & Treas
Akebia Therapeutics (AKBA)
SVP, CFO & Treas
Ranked #68,851 out of 98,743 Corporate Insiders
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-13.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jason Amello holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Mar 02, 2020 - Mar 02, 2021
Return:+61.00%
The most profitable trade made by Jason Amello
Jason Amello's Trading History
Akebia Therapeutics
Mar 02, 2020
SVP, CFO & Treas
Uninformative Buy
―
$215.52K
Acer Therapeutics
―
―
―
―
Candel Therapeutics
Nov 30, 2023
CFO
Uninformative Sell
18.14K
$1.79M
TScan Therapeutics
―
Chief Financial Officer
―
―
Alaunos Therapeutics
May 14, 2013
EVP & CFO
Uninformative Sell
4.33K
$29.54K
List of latest transactions for each holding click on a transaction to see Jason Amello's performance on stock
You May Also Like
Jason Amello insider profile FAQ
What is the percentage of profitable transactions made by Jason Amello?
The percentage of profitable transactions made by Jason Amello is 25%.
What is the average return per transaction made by Jason Amello?
The average return per transaction made by Jason Amello is -13.20%.
What stocks does Jason Amello hold?
Jason Amello holds: AKBA, ACER, CADL, TCRX, TCRT stocks.
What was Jason Amello’s latest transaction?
Jason Amello latest transaction was an Uninformative Buy of ―.
What was Jason Amello's most profitable transaction?
Jason Amello’s most profitable transaction was an Informative Sell of AKBA stock on March 2, 2020. The return on the trade was 61.00%.
What is Jason Amello's role in Akebia Therapeutics?
Jason Amello's role in Akebia Therapeutics is SVP, CFO & Treas.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.